medigraphic.com
Instituto Nacional de Salud Pública

2020, Number 3

<< Back Next >>

salud publica mex 2020; 62 (3)

Massive canine and feline vaccination in Mexico: poor governance and market failure

Hernández-Ávila M, Castro-Onofre MM, Cervantes-Trejo A

Language: Spanish
References: 25
Page: 306-312
PDF size: 262.78 Kb.


ABSTRACT

Objective. To analyze decision-making concerning stewardship and procurement mechanisms in the context of the Program for Prevention and Control of Human Rabies and the National Canine and Feline Vaccination Week in Mexico. Materials and methods. The information was obtained through requests to the National Institute of Transparency, Access to Information and Protection of Personal Data. Results. From 2009 to 2017, 158.9 million doses of canine rabies vaccine (VAR-CF) were applied with an estimated budget of 1 915 million pesos. Our findings suggest weak stewardship and ineffective governance that allows monopolistic practices and fragmented and direct purchases. Prices for the same product vary discretionally between states and are significantly higher than those offered at international level. Conclusions. After 30 years of operation of the SNVA-C in Mexico, high prices of the VAR-CF persist, which are indicative of a significant market failure, characterized by zero competition, asymmetric information and misaligned incentive structures that precluded favorable price negotiation.


REFERENCES

  1. World Health Organization. Good governance for health. Ginebra: WHO, 1998 [citado noviembre 2019]. Disponible en: https://apps.who.int/ iris/bitstream/handle/10665/65021/WHO_CHS_HSS_98.2.pdf?sequence =1&isAllowed=y

  2. Secretaría de Salud. Prevención y Control de la Rabia Humana 2013- 2018. Programa de Acción Específico. Ciudad de México: Secretaría de Salud, 2015 [citado noviembre 2019]. Disponible en: http://www. cenaprece.salud.gob.mx/descargas/pdf/PAE_PrevencionControlRabiaHumana2013_ 2018.pdf

  3. World Health Organization. ZERO BY 30: The global strategic plan to end human deaths from dog-mediated rabies by 2030. Ginebra: WHO, 2018 [citado noviembre 2019]. Disponible en: https://www.who.int/rabies/ resources/9789241513838/en/

  4. Hampson K, Dobson A, Kaare M, Dushoff J, Magoto M, Sindoya E, et al. Rabies exposures, post-exposure prophylaxis and deaths in a region of endemic canine rabies. PLoS Negl Trop Di. 2008;2(11):e339. https://doi. org/10.1371/journal.pntd.0000339 PMID: 19030223

  5. Zinsstaga J, Durra S, Pennya MA, Mindekemb R, Rotha F, Menendez- Gonzalez F, et al. Transmission dynamics and economics of rabies control in dogs and humans in an African city. Proc Natl Acad Sci U S A. 2009;106(35):14996-50001. https://doi.org/10.1073/pnas.0904740106

  6. Hampson K, Coudeville L, Lembo T, Sambo M, Kieffer A, Attlan M, et al. Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis. 2015;9(4):e0003709. https://doi.org/10.1371/journal.pntd.0003709

  7. Pan American Health Organization. Mexico is free from human rabies transmitted by dogs. Ginebra: PAHO, 2019 [citado noviembre 2019]. Disponible en https://www.paho.org/hq/index.php?option=com_content &view=article&id=15585:mexico-is-free-from-human-rabies-transmittedby- dogs&Itemid=1926&lang=en

  8. Precio internacional de referencia (OPS/PAHO), Programa Ampliado de Inmunizaciones. 8 Precios de las vacunas para el año 2018. Washington: PAHO [citado noviembre 2019]. Disponible en: https://www.paho.org/en/ tag/revolving-fund-prices

  9. Molina-Salazar R, Carbajal de Nova C. Competencia y precios en el mercado farmacéutico mexicano. Salud Publica Mex. 2008;50:(supl 4):S496-503.

  10. World Health Organization. Addressing the global shortage of medicines, and the safety and accessibility of children’s medication. Ginebra: WHO, 2015 [citado noviembre 2019]. Disponible en: https://www.who.int/medicines/ EB142_13_shortage_and_access_medicines_vaccines.pdf?ua=1

  11. Seidman G, Atun R. Do changes to supply chains and procurement processes yield cost savings and improve availability of pharmaceuticals, vaccines or health products? A systematic review of evidence from lowincome and middle-income countries. BMJ Global Health. 2017;2:e000243. https://doi.org/10.1136/bmjgh-2016-000243

  12. Schargrodsky E, Mera J, Weinschelbaum F. Transparency and acountability in Argentina´s Hospitals. En: Diagnosis corruption: fraud in Latin America´s public hospitals. Di Tella, Savedoff (eds). Washington DC: Inter American Development Bank, 2001.

  13. Arellano-García C. Acusa empresa a salud local de emitir licitaciones a modo. Periódico La Jornada. 2019 abril 9 [citado noviembre 2019]. Disponible en: https://www.jornada.com.mx/2019/04/09/ capital/028n2cap?partner=rss

  14. Muñiz É. Compra NL vacunas antirrábicas a empresa denunciada en cinco estados. Periódico La Jornada. 2014 junio 27 [citado noviembre 2019]. Disponible en: https://www.jornada.com.mx/2014/06/27/ estados/030n1est

  15. Wu SJ, Sylwestrzak G, Shah C, DeVries A. Price transparency for MRIs increased use of less costly providers and triggered provider competition. Health Aff. 2014;33:1391-8. https://doi.org/10.1377/hlthaff.2014.0168

  16. Hinsch M, Kaddar M, Schmitt S. Enhancing medicine price transparency through price information mechanisms. Global Health. 2014;10(34). https://doi.org/10.1186/1744-8603-10-34

  17. Office International des Epizooties. Manual de las pruebas de diagnóstico y de las vacunas para los animales terrestres. Capítulo 3.1.17. Rabia (infección por el virus de la rabia y otros Lyssavirus). 7 ed. París: OIE, 2018:28 [citado octubre 2019]. Disponible en: https://caninerabiesblueprint. org/IMG/pdf/oie_terrestrial_manual_2013_ch_2.1.13_rabies.pdf

  18. Vogler S, Paterson K. Can price transparency contribute to more affordable patient access to medicines? Pharmaco Economics. 2017;1:145-7. https://doi.org/10.1007/s41669-017-0028-1

  19. World Health Organization. WHO Technical Report Series, No.840, 1994. Annex 6 Requirements for rabies vaccine for veterinary use (Requirements for Biological Substances No.29, amendment 1992). Ginebra: WHO [citado octubre 2019]. Disponible en: https://www.who.int/rabies/ en/Annex_6.pdf

  20. Organización Mundial de Sanidad Animal. Manual de las Pruebas de Diagnóstico y de las Vacunas para los Animales Terrestres 2018. Capítulo 3.1.17. Rabia (infección por el virus de la rabia y otros Lyssavirus) p 28 [citado octubre 2019]. Disponible en: https://caninerabiesblueprint.org/ IMG/pdf/oie_terrestrial_manual_2013_ch_2.1.13_rabies.pdf

  21. Secretaría de Salud. Modificación a la Norma Oficial Mexicana NOM-011-SSA2-1993, Para la prevención y control de la rabia. Ciudad de México: Diario Oficial de la Federación, 1995 [citado octubre 2019]. Disponible en: http://www.salud.gob.mx/unidades/cdi/nom/m011ssa23.html

  22. Deroeck D, Bawazir SA, Carrasco P, Kaddar M, Brooks A, Fitzsimmons J, Andrus J. Regional group purchasing of vaccines: review of the Pan American Health Organization EPI revolving fund and the Gulf Cooperation Council group purchasing program. Int J Health Plann Manag. 2006;21:23-43.

  23. Pan American Health Organization. Programa ampliado de inmunizaciones. Precios de las vacunas para el año 2019. Washington: PAHO, 2019 [citado octubre 2019]. Disponible en: https://www.google.com.mx/url?sa =t&rct=j&q=&esrc=s&source=web&cd=1&ved=2ahUKEwjRmOmih6zlA hURca0KHd6jBYIQFjAAegQIABAC&url=https%3A%2F%2Fwww.paho. org%2Fhq%2Findex.php%3Foption%3Dcom_docman%26task%3Ddoc_do wnload%26gid%3D47515%26lang%3Des&usg=AOvVaw0K1-jHnElhqtJqg- ZyKhLyw

  24. Vining AR, Weimer DL. Information asymmetry favoring sellers: a policy framework. Policy Sci. 1988;21:281. https://doi.org/10.1007/BF00138305

  25. Aguilar-Arévalo MR, Ramírez-Montaño N. Diagnóstico de acceso y uso de la información pública para la exigencia colectiva de derechos. México: Nosotr@s por la Democracia, 2019 [citado octubre 2019]. Disponible en: https://nosotrxs.org/wp-content/uploads/2019/09/20190124- Diagno%cc%81stico-Nosotrxs-INAI-1.pdf




2020     |     www.medigraphic.com